Low back pain

Detalhes bibliográficos
Autor(a) principal: Stump,Patrick Raymond Nicolas André Ghislain
Data de Publicação: 2016
Outros Autores: Kobayashi,Ricardo, Campos,Alexandre Walter de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Dor
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000500063
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES: Neuropathic pain is present in 37 to 55% of cases of low back pain. Neuropathic pain is associated with more intense pain, more severe comorbidities and worse quality of life. In addition, costs are 67% higher when compared to other etiologies. The purpose of this article is to review this issue that has significant impact on quality of life. CONTENTS: Pain radiating to the lower limb may be radicular or referred pain. Radiation paths of lumbar roots and myofascial trigger points may be very similar, as the root of L5 and gluteus minimus trigger point. Thus, it is essential to use a tool for neuropathic pain assessment, such as: Douleur neuropathique 4 questionnaire, Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale e painDETECT. Clinical history and physical evaluation should formulate diagnostic hypotheses, which should be confirmed with complementary tests when necessary. Guidelines for the treatment of neuropathic pain consider as the first line drugs: anticonvulsants (gabapentin and pregabalin), tricyclic antidepressants (amitriptyline, imipramine, clomipramine and nortriptyline), selective serotonin and norepinephrine reuptake inhibitor (duloxetine and venlafaxine). Second line drugs are: 5% lidocaine patches in localized neuropathic pain and opioids. Surgical treatment of lumbar radiculopathy should be indicated when there is limited or low efficacy of multimodal conservative treatment. CONCLUSION: In low back pain, diagnosis of neuropathic component is critical. Multimodal treatment is imperative, as well as other strategies to rehabilitate and improve the patient's quality of life.
id SBED-1_25df52c10827cc90b9405109de56e022
oai_identifier_str oai:scielo:S1806-00132016000500063
network_acronym_str SBED-1
network_name_str Revista Dor
repository_id_str
spelling Low back painBack painLow back painNeuralgiaSciaticaSpinal diseasesTrigger pointsABSTRACT BACKGROUND AND OBJECTIVES: Neuropathic pain is present in 37 to 55% of cases of low back pain. Neuropathic pain is associated with more intense pain, more severe comorbidities and worse quality of life. In addition, costs are 67% higher when compared to other etiologies. The purpose of this article is to review this issue that has significant impact on quality of life. CONTENTS: Pain radiating to the lower limb may be radicular or referred pain. Radiation paths of lumbar roots and myofascial trigger points may be very similar, as the root of L5 and gluteus minimus trigger point. Thus, it is essential to use a tool for neuropathic pain assessment, such as: Douleur neuropathique 4 questionnaire, Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale e painDETECT. Clinical history and physical evaluation should formulate diagnostic hypotheses, which should be confirmed with complementary tests when necessary. Guidelines for the treatment of neuropathic pain consider as the first line drugs: anticonvulsants (gabapentin and pregabalin), tricyclic antidepressants (amitriptyline, imipramine, clomipramine and nortriptyline), selective serotonin and norepinephrine reuptake inhibitor (duloxetine and venlafaxine). Second line drugs are: 5% lidocaine patches in localized neuropathic pain and opioids. Surgical treatment of lumbar radiculopathy should be indicated when there is limited or low efficacy of multimodal conservative treatment. CONCLUSION: In low back pain, diagnosis of neuropathic component is critical. Multimodal treatment is imperative, as well as other strategies to rehabilitate and improve the patient's quality of life.Sociedade Brasileira para o Estudo da Dor2016-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000500063Revista Dor v.17 suppl.1 2016reponame:Revista Dorinstname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/1806-0013.20160051info:eu-repo/semantics/openAccessStump,Patrick Raymond Nicolas André GhislainKobayashi,RicardoCampos,Alexandre Walter deeng2016-09-22T00:00:00Zoai:scielo:S1806-00132016000500063Revistahttps://www.scielo.br/j/rdor/ONGhttps://old.scielo.br/oai/scielo-oai.phpdor@dor.org.br||dor@dor.org.br2317-63931806-0013opendoar:2016-09-22T00:00Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Low back pain
title Low back pain
spellingShingle Low back pain
Stump,Patrick Raymond Nicolas André Ghislain
Back pain
Low back pain
Neuralgia
Sciatica
Spinal diseases
Trigger points
title_short Low back pain
title_full Low back pain
title_fullStr Low back pain
title_full_unstemmed Low back pain
title_sort Low back pain
author Stump,Patrick Raymond Nicolas André Ghislain
author_facet Stump,Patrick Raymond Nicolas André Ghislain
Kobayashi,Ricardo
Campos,Alexandre Walter de
author_role author
author2 Kobayashi,Ricardo
Campos,Alexandre Walter de
author2_role author
author
dc.contributor.author.fl_str_mv Stump,Patrick Raymond Nicolas André Ghislain
Kobayashi,Ricardo
Campos,Alexandre Walter de
dc.subject.por.fl_str_mv Back pain
Low back pain
Neuralgia
Sciatica
Spinal diseases
Trigger points
topic Back pain
Low back pain
Neuralgia
Sciatica
Spinal diseases
Trigger points
description ABSTRACT BACKGROUND AND OBJECTIVES: Neuropathic pain is present in 37 to 55% of cases of low back pain. Neuropathic pain is associated with more intense pain, more severe comorbidities and worse quality of life. In addition, costs are 67% higher when compared to other etiologies. The purpose of this article is to review this issue that has significant impact on quality of life. CONTENTS: Pain radiating to the lower limb may be radicular or referred pain. Radiation paths of lumbar roots and myofascial trigger points may be very similar, as the root of L5 and gluteus minimus trigger point. Thus, it is essential to use a tool for neuropathic pain assessment, such as: Douleur neuropathique 4 questionnaire, Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale e painDETECT. Clinical history and physical evaluation should formulate diagnostic hypotheses, which should be confirmed with complementary tests when necessary. Guidelines for the treatment of neuropathic pain consider as the first line drugs: anticonvulsants (gabapentin and pregabalin), tricyclic antidepressants (amitriptyline, imipramine, clomipramine and nortriptyline), selective serotonin and norepinephrine reuptake inhibitor (duloxetine and venlafaxine). Second line drugs are: 5% lidocaine patches in localized neuropathic pain and opioids. Surgical treatment of lumbar radiculopathy should be indicated when there is limited or low efficacy of multimodal conservative treatment. CONCLUSION: In low back pain, diagnosis of neuropathic component is critical. Multimodal treatment is imperative, as well as other strategies to rehabilitate and improve the patient's quality of life.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000500063
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000500063
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1806-0013.20160051
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv Revista Dor v.17 suppl.1 2016
reponame:Revista Dor
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str Revista Dor
collection Revista Dor
repository.name.fl_str_mv Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dor@dor.org.br||dor@dor.org.br
_version_ 1752126255480700928